Kristy Maag
Gerontology · Long Branch, NJNPI 1316334212
Payments from drug & device makers
Across 34 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$70
- Johnson & Johnson$66
- Daiichi Sankyo Inc.$61
- Taiho Oncology, Inc.$56
- Eisai Inc.$54
- Puma Biotechnology, Inc.$49
- plus $261 from 11 others
What the payments were for
- Food & beverage$60097%
- Education$173%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 4 | $70 |
| Johnson & Johnson(2 entities) | 4 | $66 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Taiho Oncology, Inc. | 3 | $56 |
| Eisai Inc. | 3 | $54 |
| Puma Biotechnology, Inc. | 3 | $49 |
| Dendreon Pharmaceuticals LLC | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Genentech USA, Inc. | 2 | $35 |
| Novartis | 1 | $23 |
| Pfizer | 1 | $21 |
| Novocure Inc. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Emmaus Medical, Inc. | 1 | $17 |
| Genmab U.S., Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $15 |
| AbbVie | 1 | $13 |
How this compares
$617 in reported general payments places this provider in the 65th percentile of 374 gerontology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lenalidomide | 18 | $243,371 |
| OxycontinOxycodone Hcl | 22 | $50,021 |
| Fentanyl | 21 | $5,497 |
| Hydromorphone Hcl | 112 | $4,744 |
| Oxycodone Hcl | 131 | $3,020 |
| Morphine Sulfate | 44 | $1,129 |
| Acyclovir | 43 | $635 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $345 |
| Levofloxacin | 11 | $295 |
| Hydroxyurea | 15 | $193 |
| Pantoprazole Sodium | 16 | $169 |
| Gabapentin | 17 | $111 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $92 |
| Ondansetron Hcl | 13 | $89 |
| Prochlorperazine Maleate | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Long Branch
- Lisa MalakToms River$162K
- Dana JonesTeaneck$150K
- Jennifer FoxFlemington$76K
- Susan HermidaBrick$33K
- Jihane SaadeNorth Bergen$9K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.